These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24332927)

  • 21. Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns.
    Chatterton DE; Nguyen DN; Bering SB; Sangild PT
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1730-47. PubMed ID: 23660296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor-beta: an important role in CD4+CD25+ regulatory T cells and immune tolerance.
    Zhang L; Yi H; Xia XP; Zhao Y
    Autoimmunity; 2006 Jun; 39(4):269-76. PubMed ID: 16891215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Transforming growth factor-beta controls pathogenesis of Crohn disease].
    Friess H; di Mola FF; Egger B; Scheuren A; Kleeff J; Zimmermann A; Büchler MW
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():994-7. PubMed ID: 9931770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of TGF-beta/Smad signaling pathway on lung myofibroblast differentiation.
    Gu L; Zhu YJ; Yang X; Guo ZJ; Xu WB; Tian XL
    Acta Pharmacol Sin; 2007 Mar; 28(3):382-91. PubMed ID: 17303001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of growth factors in peritoneal healing: transforming growth factor beta (TGF-beta).
    Chegini N
    Eur J Surg Suppl; 1997; (577):17-23. PubMed ID: 9076448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The balance of intestinal Foxp3+ regulatory T cells and Th17 cells and its biological significance.
    Shen X; Du J; Guan W; Zhao Y
    Expert Rev Clin Immunol; 2014 Mar; 10(3):353-62. PubMed ID: 24483245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of interleukin-10 or transforming growth factor β signaling in the human colon initiates a T-helper 1 response via distinct pathways.
    Jarry A; Bossard C; Sarrabayrouse G; Mosnier JF; Laboisse CL
    Gastroenterology; 2011 Nov; 141(5):1887-96.e1-2. PubMed ID: 21839042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transforming growth factor-beta: a general review.
    Lawrence DA
    Eur Cytokine Netw; 1996 Sep; 7(3):363-74. PubMed ID: 8954178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TGF-beta as a promising option in the treatment of multiple sclerosis.
    Mirshafiey A; Mohsenzadegan M
    Neuropharmacology; 2009; 56(6-7):929-36. PubMed ID: 19285095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of tolerance induced by transforming growth factor-beta-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand.
    Kosiewicz MM; Alard P; Liang S; Clark SL
    Int Immunol; 2004 May; 16(5):697-706. PubMed ID: 15096489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CpG motifs of bacterial DNA exert protective effects in mouse models of IBD by antigen-independent tolerance induction.
    Bleich A; Janus LM; Smoczek A; Westendorf AM; Strauch U; Mähler M; Hedrich HJ; Fichtner-Feigl S; Schölmerich J; Falk W; Hofmann C; Obermeier F
    Gastroenterology; 2009 Jan; 136(1):278-87. PubMed ID: 18952084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Transforming growth factor-betas: smad signaling and roles in physiopathology].
    Javelaud D; Mauviel A
    Pathol Biol (Paris); 2004 Feb; 52(1):50-4. PubMed ID: 14761714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immune responses in intestinal mucosa].
    Kanai T; Watanabe M
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():459-67. PubMed ID: 15861696
    [No Abstract]   [Full Text] [Related]  

  • 34. Shikonin promotes intestinal wound healing in vitro via induction of TGF-β release in IEC-18 cells.
    Andújar I; Ríos JL; Giner RM; Recio MC
    Eur J Pharm Sci; 2013 Jul; 49(4):637-41. PubMed ID: 23727294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral and intestinal CD4+ T cells with a regulatory phenotype in pediatric patients with inflammatory bowel disease.
    La Scaleia R; Morrone S; Stoppacciaro A; Scarpino S; Antonelli M; Bianchi E; Di Nardo G; Oliva S; Viola F; Cucchiara S; Santoni A; Palmieri G; Uccini S
    J Pediatr Gastroenterol Nutr; 2010 Nov; 51(5):563-72. PubMed ID: 20890221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TGF-beta/Smad signaling defects in inflammatory bowel disease: mechanisms and possible novel therapies for chronic inflammation.
    Fiocchi C
    J Clin Invest; 2001 Aug; 108(4):523-6. PubMed ID: 11518725
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of transforming growth factor-beta in atherosclerosis.
    Singh NN; Ramji DP
    Cytokine Growth Factor Rev; 2006 Dec; 17(6):487-99. PubMed ID: 17056295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SMAD regulatory networks construct a balanced immune system.
    Malhotra N; Kang J
    Immunology; 2013 May; 139(1):1-10. PubMed ID: 23347175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TGF-beta down-regulates IL-6 signaling in intestinal epithelial cells: critical role of SMAD-2.
    Walia B; Wang L; Merlin D; Sitaraman SV
    FASEB J; 2003 Nov; 17(14):2130-2. PubMed ID: 14500551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TGF-beta and fibrosis in different organs - molecular pathway imprints.
    Pohlers D; Brenmoehl J; Löffler I; Müller CK; Leipner C; Schultze-Mosgau S; Stallmach A; Kinne RW; Wolf G
    Biochim Biophys Acta; 2009 Aug; 1792(8):746-56. PubMed ID: 19539753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.